About 30% of HER2-positive breast tumors express a group of truncated HER2 segment collectively named as p95-HER2, and also known as the p95-HER2/611 carboxy terminal fragment (CTF) and p110 (25). The gene discussed is ERBB2; the disease is breast neoplasm.